News | March 19, 2024
Dr. Reddy's Laboratories launches Versavo in the UK
Versavo is the first Dr. Reddy's biosimilar product to be approved and launched in the UK
Versavo is the first Dr. Reddy's biosimilar product to be approved and launched in the UK
The drug will target specific genetic mutations prevalent in certain types of cancers
It is indicated for the inhibition of premature luteinizing hormone (LH) surges in women undergoing controlled ovarian hyperstimulation
The 200 bedded hospital owned & operated by Alexis
Submission to be reviewed under FDA real-time oncology review and Project Orbis
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
Cyclophosphamide is a chemotherapy medication that slows the growth of cancer cell
Express Scripts to add Zepbound to National Preferred Formulary
The product will be manufactured at Lupin’s Nagpur facility in India
Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months
Subscribe To Our Newsletter & Stay Updated
